Mile Brujic, OD, FAAO

Mile Brujic, OD, FAAO, outlines the essentials to starting a speciality contact lens practice, including speciality competency and accessing resources.

Perfluorohexyloctane may slow evaporation to reduce dry eye.

Mile Brujic, OD, FAAO, speaks on the power of Rinsada to bust biofilms at Vision Expo East 2024.

Michael Wolber, CEO of OCULUS USA, sits down with host Mile Brujic, OD, FAAO, to wander through Wolber's engineering background, his accidental passion for eye care, and how he envisions OCULUS paving the way for improved patient care.

Noninvasive treatments can help patients with ptosis improve their visual field.

Dr Mile Brujic discusses his EyeCon presentations, which spanned from antibody drug conjugates (ADCs) and their effect on ocular toxicity for patients with cancer to innovations in eye care.

2 cases illustrate the importance of ocular surface optimization.

Bobak Azamian, MD, PhD, sits down with host Mile Brujic, OD, FAAO, to dive into his journey into eye care, the mantel of responsibility he carries as CEO of Tarsus Pharmaceuticals, and what makes him tick.

Therapies and technologies to treat allergic conjunctivitis are rapidly changing.

Mile Brujic, OD, FAAO, discusses the use of specialty lenses vs glasses in some patients, as well as approaches to managing the symptoms of dry eye disease.

Mile Brujic, OD, FAAO, presents a patient case of a 67-year-old woman with dry eye disease and a history of radial keratotomy (RK) surgery.

Mile Brujic, OD, FAAO, shares considerations from a patient case, highlighting diagnostic tools in dry eye disease as well as the ability of the patient to use medication.

Mile Brujic, OD, FAAO, presents the case of a 42-year-old female patient with dry eye disease who has discomfort using eyedrops.

Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation, which covered 12 new treatments all optometrists should know about.

Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation that discussed the pharmaceutical treatment of anterior segment inflammatory conditions.

Both are critical to successful treatment, but how can optometrists help?

Mile Brujic, OD, shares highlights from his SECO 2023 presentation, "Learning about the Lid: Optimizing recognition, diagnosis, and treatment of Demodex blepharitis and blepharoptosis."

Mile Brujic, OD, shares highlights from his SECO 2023 poster presentation on confocal scanning laser imaging and patient care.

Mile Brujic, OD, FAAO, shares key takeaways from his EyeCon 2022 presentation, "Advances in presbyopia."

Preservative-free eye drops offer benefits for ocular health.

During AOA 2022, Mile Brujic, OD, FAAO, shares his advice and best practices for new optometry school grads on how to be financially smart.

A pharmaceutical approach (pilocarpine hydrochloride ophthalmic solution 1.25% ) to improving near vision can be used with other technology, benefiting a wide variety of patients.

Physicians share tales of creative workarounds to cope with this condition.

Mile Brujic, OD, FAAO, speaks on why he views diagnostics and pharmaceuticals as the best technological advancements in eyecare.

Apply this technology to assess corneal clearance and improve fitting success

Ophthalmic corticosteroids optimize outcomes in patients with ocular inflammatory conditions

Combing through diagnostic information and inflammation measurements gives ODs the tools to create targeted approaches to dry eye treatment, including when to drug and when to plug

Lid wiper epitheliopathy is a critical clinical marker that will not only help identify an abnormality in ocular surface homeostasis, but also a key clinical marker to track when treating a patient for dry eye